Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.48) per share. This is a 29.73 percent decrease over losses of $(0.37) per share from the same period last year.
Wells Fargo Maintains Overweight on Ecolab, Raises Price Target to $175
Wells Fargo analyst Seth Weber maintains Ecolab (NYSE:ECL) with a Overweight and raises the price target from $168 to $175.